Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

A new gene, JMJD1C, may affect testosterone levels in men.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Dutasteride and finasteride affect different cell types differently.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Testosterone significantly affects urination differences between male and female mice.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.